Cord blood transfusions could be safer for preterm babies
NCT ID NCT07502781
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares transfusions using red blood cells from umbilical cord blood versus standard adult donor blood in extremely premature infants. About 176 babies born before 28 weeks or weighing under 1000 grams will be enrolled. The goal is to see if cord blood reduces the risk of serious complications like lung disease, eye problems, or death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- umbilical cord blood red blood cells
- What this could lead to
- If it works, this could provide a safer and more effective transfusion option for extremely premature babies, reducing complications like lung and eye problems.
- What could go wrong
- This is a small pilot study, so results may not be conclusive. Cord blood may not always be available, and the benefits over standard blood are still unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA NEONATAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clínic de Barcelona - Maternitat
Barcelona, 08028, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- Could a simple blood test flag lung risk in preemies?
- A new window into Babies' eyes: can advanced imaging improve care for premature infants?
- Can a gentle eye scan replace stressful exams for preterm infants?
- Can smarter screening save premature Babies' sight?
- Can a lower dose of an eye drug protect preterm Infants' sight?